GSK PLC GSK shares inched down 0.90% to £13.22 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 1.14% to 8,105.32.

智通财经APP获悉，GSK (GSK.US)日前宣布，美国FDA已授予其PD-1抑制剂Jemperli (dostarlimab)用于治疗局部晚期错配修复缺陷 (dMMR)/高微卫星不稳定性 (MSI-H)直肠癌的突破性疗法认定 (BTD)。 这是dostarlimab在局部晚期dMMR/MSI-H直肠癌适应症上获得的第二项监管认定，该疗法在2023年1月曾获FDA授予快速通道资格。

在2024年最后几个月跌下高位后，欧洲医疗保健股在新的一年里面临着美国政治和高风险新药试验结果的风险。数据显示，斯托克600医疗保健指数(Stoxx 600 Health Care ...

Deutsche Bank has recently reduced GSK plc (GSK) stock to Hold rating, as announced on November 15, 2024, according to Finviz. Earlier, on November 12, 2024, Jefferies had reduced the stock from a Buy ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...

It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among bigwigs, Gilead Sciences, Inc.

Pfizer’s financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a "Buy" ...

Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and Robert F. Kennedy Jr. as the possible HHS lead.

Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on December 11.Pick the ...

As 2024 draws to a close, we explore five stocks to buy for a new year that promises opportunity alongside uncertainty ...

Biogen (BIIB) closed near a 52-week low of $150.03. The stock trades at a discount because the biotech firm lacks growth ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.01% of ...